Free Trial

Michael Sarcone Analyst Performance

Analyst at Jefferies Financial Group

Michael Sarcone is a stock analyst at Jefferies Financial Group in the medical sector, covering 4 publicly traded companies. Over the past year, Michael Sarcone has issued 7 stock ratings, including buy and hold recommendations. While full access to Michael Sarcone's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Sarcone's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 1 Years
Buy Recommendations
14.29% 1 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy14.3%1 ratings
Hold85.7%6 ratings
Sell0.0%0 ratings

Out of 7 total stock ratings issued by Michael Sarcone at Jefferies Financial Group, the majority (85.7%) have been Hold recommendations, followed by 14.3% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
3 companies
NYSE
25.0% of companies on NYSE
1 company

Michael Sarcone, an analyst at Jefferies Financial Group, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Michael Sarcone of Jefferies Financial Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
2 companies
50.0%
MEDICAL INFO SYS
1 company
25.0%
MED/DENTAL - SUPP
1 company
25.0%

Michael Sarcone's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2/12/2026Lower Price Target$59.31$66.00Hold
Align Technology, Inc. stock logo
ALGN
Align Technology
2/5/2026Boost Price Target$175.62$185.00Hold
AxoGen, Inc. stock logo
AXGN
AxoGen
12/4/2025Boost Price Target$28.33$36.00Buy
Edap Tms S.A. stock logo
EDAP
Edap Tms
11/6/2025Reiterated Rating$1.99$2.00Hold
Align Technology, Inc. stock logo
ALGN
Align Technology
10/30/2025Boost Price Target$138.43$155.00
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
10/24/2025Reiterated Rating$80.11$85.00Hold
Align Technology, Inc. stock logo
ALGN
Align Technology
10/10/2025Reiterated Rating$131.87$140.00Hold
Edap Tms S.A. stock logo
EDAP
Edap Tms
4/4/2025Reiterated Rating$1.91$2.00Hold